Council of Scientific and Industrial Research

Anil Kumar Rastogi

Arvind Kumar Srivastava

Deepak Raina

Ram Pratap

Nitya Anand

Satyawan Singh

Ramesh Chander

Sudhir Srivastava

Anju Puri

Ram Chandra Gupta

Omkar Prasad Asthana

Raghwendra Pal

Ashok Kumar Khanna

Ramesh Chandra

Narinder Kumar Kapoor

Satyavan Singh

Savita Srivastava

Swarn Nityanand

Ashim Ghatak

Sukh Dev

Rajesh Kumar

Suprabhat Ray

Atul Kumar

Chandeshwar Nath

Ram Raghubir

Onkar Prasad Asthana

Hemant Kumar Singh

Poonam Gupta

Arivend Srivastava

Priti Tewari

Rehan Ahmad

Narender Tadigoppula

Ramaesh Chander

Geetika Bhatia

Brijendra Kumar Tripathi

Farhar Rivizvi

Girja Shankar

Depak Raina

Arwind Kumar Srivastava

Puvvada Sri Ramachandra Murthy

Preeti Tiwari

Narenda Singh

Nitya Nand

Mahendra Nath Srivastava

Lakshmi Vijay

Vijai Lakshmi

Kartikay Pandey

Raja Roy

Bhawani Shankar Joshi

Padmanabhan Madhusudanan Kunnath

Ajet Saxena

Devdutt Chaturvedi

Reema Rastogi

A bioactive fraction obtained fromthat is useful for the treatment of diabetes and dyslipidemia. This fraction can be provided in a pharmaceutical composition that is useful as antidiabetic and antidyslipidemic agent, or can be used in a method of treating diabetes and dyslipidemia in a subject. Also, a process for the preparation of bioactive fraction from. Isomeric xyloccensins and the preparation of such compounds. Also, pharmaceutical compositions comprising a therapeutically effective amount of such isomeric xyloccensins optionally along with one or more pharmaceutically acceptable carriers, additives, lubricant and diluents and the use of such pharmaceutical compositions in a method for treating dyslipidemia.

Pharmaceutical composition for treatment of diabetes and dyslipidemia

The present invention provides a novel saponin tigogenin penta glycoside isolated from the aerial parts ofand a process for the isolation thereof as well as its use in anti-hyperglycemic and hypolipidemic activities.

[object Object]

This invention relates to novel {overscore (&#x3c9;)}-substituted-naphthyloxy-amino alkanes, their preparation and use as antihyperglycemic agents and for the treatment and prevention of cardiovascular disorders (CVS) such as lipid lowering effects.

Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders

The present invention provides new uses of Gugulipid, an ethyl acetate extract of the resin of the plant, for controlling or preventing cognitive dysfunction, hyperglycemia and some infective conditions of the skin and a method of preparing Gugulipid by agitating the resin in shake flask assembly or sonicating assembly and preparing a solid or a creamy dosage forms.

Method of treating a cognitive memory dysfunction using Gugulipid

The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein belowWherein X&#x2550;OH or O or combination thereof and positioning of olefinic bonds are at 4(5); 5(6); 16(17); 17(20) or various combinations and said compounds containing at least one olefinic bond in or on their D-ring for the treatment of hyperlipidemic and hyperglycemic conditions in mammals, said method comprising administering an effective amount of the said compounds to the recipient mammals.

Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones

Growing community of inventors

Lucknow, India

Anil Kumar Rastogi